Updated Jul 16, 2026
Lippis Daniel J. has filed 7 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.06M.
Daniel J. Lippis is a corporate executive at Edwards Lifesciences Corp, where he serves as the Chief Vice President for the JAPAC region. He has been involved in multiple SEC filings related to his role but has not reported any stock transactions.
| Role | CVP, TAVR |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-10 | EW | Edwards Lifesciences Corp | S — Open-market sale | 619 | $91.70 | $57K |
| 2026-07-10 | EW | Edwards Lifesciences Corp | M — Option exercise | 619 | $72.68 | $45K |
| 2026-07-07 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 377 | $95.18 | $36K |
| 2026-07-01 | EW | Edwards Lifesciences Corp | S — Open-market sale | 619 | $91.40 | $57K |
| 2026-07-01 | EW | Edwards Lifesciences Corp | M — Option exercise | 619 | $72.68 | $45K |
| 2026-05-18 | EW | Edwards Lifesciences Corp | S — Open-market sale | 620 | $81.14 | $50K |
| 2026-05-18 | EW | Edwards Lifesciences Corp | M — Option exercise | 620 | $72.68 | $45K |
| 2026-05-12 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 362 | $79.96 | $29K |
| 2026-05-09 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 450 | $82.76 | $37K |
| 2026-05-09 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 309 | $83.20 | $26K |
| 2026-05-09 | EW | Edwards Lifesciences Corp | A — Grant or award | 7.8K | $0.00 | |
| 2026-05-04 | EW | Edwards Lifesciences Corp | S — Open-market sale | 1.0K | $83.98 | $86K |
| 2026-05-04 | EW | Edwards Lifesciences Corp | M — Option exercise | 1.0K | $59.26 | $60K |
| 2026-05-04 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 252 | $83.98 | $21K |
| 2026-05-04 | EW | Edwards Lifesciences Corp | S — Open-market sale | 1.0K | $82.99 | $83K |
| 2026-05-04 | EW | Edwards Lifesciences Corp | S — Open-market sale | 19 | $83.99 | $2K |
| 2026-05-04 | EW | Edwards Lifesciences Corp | M — Option exercise | 1.0K | $59.26 | $60K |
| 2026-04-07 | EW | Edwards Lifesciences Corp | S — Open-market sale [10b5-1] | 1.0K | $80.98 | $83K |
| 2026-04-07 | EW | Edwards Lifesciences Corp | M — Option exercise [10b5-1] | 1.0K | $59.26 | $60K |
| 2026-03-11 | EW | Edwards Lifesciences Corp | S — Open-market sale [10b5-1] | 1.0K | $85.38 | $87K |
Daniel J. Lippis is a corporate executive at Edwards Lifesciences Corp, where he serves as the Chief Vice President for the JAPAC region. He has been involved in multiple SEC filings related to his role but has not reported any stock transactions.…
7 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 12 open-market sales ($1.06M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lippis Daniel J. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.